Published in J Interv Card Electrophysiol on March 01, 2001
[Right atrial ablation of ectopic atrial tachycardia using a 20-pole mapping catheter]. Herzschrittmacherther Elektrophysiol (2006) 0.75
Activation mapping of focal atrial tachycardia: the impact of the method for estimating activation time. J Interv Card Electrophysiol (2009) 0.75
A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart. In vitro and in vivo accuracy results. Circulation (1997) 3.13
Transcatheter ablation of ectopic atrial tachycardia in young patients using radiofrequency current. Circulation (1992) 1.92
Radiofrequency catheter ablation of atrial arrhythmias. Results and mechanisms. Circulation (1994) 1.64
Radiofrequency catheter ablation of ectopic atrial tachycardia using paced activation sequence mapping. J Am Coll Cardiol (1993) 1.39
Radiofrequency ablation for treatment of primary atrial tachycardias. J Am Coll Cardiol (1993) 1.37
Radiofrequency catheter ablation of atrial tachycardias. Am Heart J (1996) 1.30
Estimating cardiac transmembrane activation and recovery times from unipolar and bipolar extracellular electrograms: a simulation study. Circ Res (1989) 1.22
Electrogram patterns predictive of successful catheter ablation of accessory pathways. Value of unipolar recording mode. Circulation (1991) 1.21
Interaction of inhomogeneities of repolarization with anisotropic propagation in dog atria. A mechanism for both preventing and initiating reentry. Circ Res (1989) 1.20
New method for nonfluoroscopic endocardial mapping in humans: accuracy assessment and first clinical results. Circulation (1998) 1.19
Use of a three-dimensional, nonfluoroscopic mapping system for catheter ablation of typical atrial flutter. Pacing Clin Electrophysiol (1998) 1.06
High-density mapping of activation through an incomplete isthmus ablation line. Circulation (1999) 1.03
Epicardial mapping: how to measure local activation? Pacing Clin Electrophysiol (1990) 0.97
Unipolar electrogram characteristics predictive of successful radiofrequency catheter ablation of accessory pathways. J Cardiovasc Electrophysiol (2000) 0.91
Three-dimensional electromagnetic catheter technology: electroanatomical mapping of the right atrium and ablation of ectopic atrial tachycardia. J Cardiovasc Electrophysiol (1997) 0.87
Response to pacing at sites of isolated diastolic potentials during ventricular tachycardia in patients with previous myocardial infarction. J Am Coll Cardiol (1997) 0.85
Evidence of abnormal automaticity and triggering activity in incessant ectopic atrial tachycardia. Am Heart J (1988) 0.83
Role of catheter-induced mechanical trauma in localization of target sites of radiofrequency ablation in automatic atrial tachycardia. J Am Coll Cardiol (1996) 0.79
Is there an isolated arrhythmogenic right atrial myocarditis? Eur Heart J (1990) 0.78
Global biodiversity conservation priorities. Science (2006) 11.20
Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med (1997) 6.17
Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation (2001) 5.87
Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res (2001) 3.89
Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet (2000) 3.31
Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers : evidence for a dysfunctional nitric oxide synthase. Circ Res (2000) 2.52
Immune response restoration with macrophage culture supernatants. Science (1971) 2.37
Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation (1999) 2.05
Phosphorylation by G1-specific cdk-cyclin complexes activates the nucleolar transcription factor UBF. EMBO J (1999) 2.04
The effect of aortic valve replacement on survival. Circulation (1982) 2.03
Wet combing for head lice: feasibility in mass screening, treatment preference and outcome. J R Soc Med (2002) 1.82
Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia (2000) 1.74
The antigen specificity of thymus-derived helper cells. J Immunol (1972) 1.70
Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol (1984) 1.62
An anatomically and electrogram-guided stepwise approach for effective and safe catheter ablation of the fast pathway for elimination of atrioventricular node reentrant tachycardia. J Am Coll Cardiol (1995) 1.61
Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. Circ Res (2000) 1.60
Regulation of the immune response. II. Qualitative and quantitative differences between thymus- and bone marrow-derived lymphocytes in the recognition of antigen. J Exp Med (1973) 1.57
The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review. Pharmacoepidemiol Drug Saf (2013) 1.53
Coronary angioplasty in octogenarians. Quality of life and costs. Eur Heart J (1999) 1.50
Prevalence, circumstances, mechanisms, and risk stratification of sudden cardiac death in unipolar single-chamber ventricular pacing. Circulation (1992) 1.50
Holt-Oram syndrome. Circulation (1999) 1.49
Successful radiofrequency catheter ablation of right sided accessory pathways during sustained atrial fibrillation. Eur Heart J (1995) 1.47
Chiari's network: normal anatomic variant or risk factor for arterial embolic events? J Am Coll Cardiol (1995) 1.43
Antibodies to chlamydial lipopolysaccharides in unstable angina pectoris. Am J Cardiol (2001) 1.42
Membrane-covered stents: a new treatment strategy for saphenous vein graft lesions. Catheter Cardiovasc Interv (2001) 1.42
Long-term antiarrhythmic therapy with flecainide. Am J Cardiol (1984) 1.39
Protection of side-branches in coronary lesions with a new stent design. Cathet Cardiovasc Diagn (1998) 1.39
Prevalence of circadian variations and spontaneous variability of cardiac disorders and ECG changes suggestive of myocardial ischemia in systemic arterial hypertension. Circulation (1992) 1.39
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis. Clin Infect Dis (2016) 1.39
[The effect of a lower stimulation frequency on the AV synchronicity of VDD pacemakers]. Dtsch Med Wochenschr (1997) 1.38
[Angina pectoris in normal coronary arteries (microvascular angina/syndrome X)]. Dtsch Med Wochenschr (1997) 1.38
[A 73-year-old patient with hypertensive crisis. Was the use of calcium antagonist nifedipine justified?]. Internist (Berl) (1999) 1.38
Peritoneal macrophages in the immune response to SRBC in vitro. Immunology (1970) 1.35
Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events. J Am Coll Cardiol (1990) 1.29
Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability. Circ Res (2000) 1.27
Impact of long-term ECG recording on the detection of paroxysmal atrial fibrillation in patients after an acute ischemic stroke. Pacing Clin Electrophysiol (1999) 1.26
MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis. Mult Scler (2006) 1.25
Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int (1999) 1.25
Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta. Circulation (2001) 1.24
Catheter ablation of atrial flutter guided by electroanatomic mapping (CARTO): a randomized comparison to the conventional approach. J Cardiovasc Electrophysiol (2000) 1.23
Regulation of the immune response. I. Differential effect of passively administered antibody on the thymus-derived and bone marrow-derived lymphocytes. J Exp Med (1971) 1.23
Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. Biochem Biophys Res Commun (1999) 1.22
Constitutive and strong association of PAF53 with RNA polymerase I. Chromosoma (1997) 1.22
Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress. Free Radic Biol Med (2001) 1.21
Intracoronary thrombolysis with an acylated streptokinase-plasminogen activator (BRL 26921) in patients with acute myocardial infarction. J Am Coll Cardiol (1984) 1.21
Pharmacokinetics of the enantiomers of acenocoumarol in man. Br J Clin Pharmacol (1981) 1.19
From single cells to tissue architecture-a bottom-up approach to modelling the spatio-temporal organisation of complex multi-cellular systems. J Math Biol (2008) 1.18
Calculating absorption shifts for retinal proteins: computational challenges. J Phys Chem B (2005) 1.18
Influence of insulin on cyclic 3',5'-AMP phosphodiesterase activity in liver, skeletal muscle, adipose tissue, and kidney. Diabetologia (1968) 1.18
Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His. Neurology (2009) 1.18
The enantiomers of phenprocoumon: pharmacodynamic and pharmacokinetic studies. Clin Pharmacol Ther (1976) 1.17
Yeast cycloheximide-resistant crl mutants are proteasome mutants defective in protein degradation. Mol Biol Cell (1997) 1.16
Flow-dependent coronary artery dilatation in humans. Circulation (1989) 1.16
New insights into the epidemiology and etiology of Fournier's gangrene: a review of 33 patients. Infection (2009) 1.15
A critical evaluation of different QM/MM frontier treatments with SCC-DFTB as the QM method. J Phys Chem B (2005) 1.15
Regulation of the immune response. IV. Antibody-mediated suppression of the immune response to haptens and heterologous erythrocyte antigens in vitro. J Immunol (1973) 1.14
A retrospective evaluation of the global decline of carnivores and ungulates. Conserv Biol (2014) 1.13
Leaf traits and herbivory rates of tropical tree species differing in successional status. Plant Biol (Stuttg) (2004) 1.13
RNA degradation buffers asymmetries of transcription in Arabidopsis mitochondria. EMBO Rep (2000) 1.12
Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma. Int J Cancer (2000) 1.12
Wet combing versus traditional scalp inspection to detect head lice in schoolchildren: observational study. BMJ (2000) 1.10
Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial. Circulation (1989) 1.09
Echocardiography in assessing acute pulmonary hypertension due to pulmonary embolism. Am J Cardiol (1980) 1.09
[Policy paper to the cardiac re-sychronization therapy]. Z Kardiol (2003) 1.09
Activated human B cells display a functional IL 2 receptor. J Immunol (1985) 1.09
Highly efficient optically pumped vertical-emitting semiconductor laser with more than 20 W average output power in a fundamental transverse mode. Opt Lett (2008) 1.09
Array-CGH analysis in patients with syndromic and non-syndromic XY gonadal dysgenesis: evaluation of array CGH as diagnostic tool and search for new candidate loci. Hum Reprod (2010) 1.08
Beta-blocker withdrawal syndrome? Lancet (1979) 1.08
Interruption of the enterohepatic circulation of phenprocoumon by cholestyramine. Clin Pharmacol Ther (1977) 1.07
Enhanced elimination of warfarin during treatment with cholestyramine. Br J Clin Pharmacol (1978) 1.06
In vitro hymenoptera venom allergy diagnosis: improved by screening for cross-reactive carbohydrate determinants and reciprocal inhibition. Allergy (2006) 1.06
ECG variants and cardiac arrhythmias in athletes: clinical relevance and prognostic importance. Am Heart J (1990) 1.05
Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings. Am J Cardiol (1996) 1.05
Toward theoretical analysis of long-range proton transfer kinetics in biomolecular pumps. J Phys Chem A (2006) 1.04
Single photon emission and cerebral computerised tomographic scan and transcranial Doppler sonographic findings in eclampsia. Br J Obstet Gynaecol (1997) 1.04
Effects of glucocorticoids and insulin on 3',5'-AMP phosphodiesterase activity in adrenalectomized rats. Diabetologia (1968) 1.04
A transgenic approach to the study of peripheral T-cell tolerance. Immunol Rev (1991) 1.03
[Influence of hydrochlorothiazide and other sulfamoyl diuretics on the activity of 3',5'-AMP phosphodiesterase in rat kidney]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 1.03
Vascular endothelial growth factor in pleural effusions of different origin. Eur Respir J (2005) 1.02
Spin trapping of vascular nitric oxide using colloid Fe(II)-diethyldithiocarbamate. Biochem Biophys Res Commun (2000) 1.02
Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial. Br J Cancer (2008) 1.01
Several unsuccessful internal and external defibrillations during active can ICD implantation in a patient with pneumothorax. Pacing Clin Electrophysiol (1998) 1.01
Anticoagulant activity of the enantiomers of acenocoumarol. Br J Clin Pharmacol (1978) 1.00
Risk of transesophageal echocardiography in awake patients with cardiac diseases. Am J Cardiol (1988) 1.00
Gastric carcinoma with osteoclast-like giant cells and lymphoepithelioma-like carcinoma of the stomach: two of a kind? Histopathology (2005) 1.00
Localization and radiofrequency catheter ablation of left-sided accessory pathways during atrial fibrillation. Feasibility and electrogram criteria for identification of appropriate target sites. J Am Coll Cardiol (1995) 1.00
Oxidative stress increases endothelin-1 synthesis in human coronary artery smooth muscle cells. J Cardiovasc Pharmacol (2001) 0.99
Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1). Br J Dermatol (2011) 0.99
Probable clonal genesis of cellular islands induced in rat liver by diethylnitrosamine. Eur J Cancer (1971) 0.98
Role for NADPH/NADH oxidase in the modulation of vascular tone. Ann N Y Acad Sci (1999) 0.98
Tachyarrhythmias following coronary artery bypass graft surgery: epidemiology, mechanisms, and current therapeutic strategies. Thorac Cardiovasc Surg (1997) 0.98
Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study. Pharmacopsychiatry (2002) 0.98
18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading. Ann Oncol (2006) 0.97
[Intermittent atrial fibrillation/flutter: contraindication for implantation of a dual chamber pacemaker?]. Z Kardiol (1996) 0.97
Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea. Pediatr Dermatol (2001) 0.97
Coronary artery anomalies. Part I: Recent insights from molecular embryology. Z Kardiol (2004) 0.97